noevir holdingsnoevir holdings co.,ltd.4928東証プライム化学FY ending Sep 2025, consolidated, J-GAAP

noevir holdings FY ending Sep 2019 results

About 79% of noevir holdings's sales come from Cosmetics, with Medicine and grocery making up much of the rest.

Out of every ¥100 of sales, about ¥20 is left as operating profit.

Where the money goes

※ Segment revenues include inter-segment sales and are scaled to consolidated revenue

Where ¥100 of sales goes

For every ¥100 noevir holdings sells, how much goes where, and how much is kept.

FY ending Sep 2019
Cost of sales
¥36
SG&A
¥44
Operating profit
¥20
Net profit kept
¥12

Margin funnel (derived from reported values)Gross margin 64.5% → Operating margin 20.2% → Net margin 12.2%

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Sep 2019

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (3)
  • EDINET (FSA Japan)

    有価証券報告書-第13期(2022/10/01-2023/09/30)

    ID S100SEXP2023-12-08Open
  • EDINET (FSA Japan)

    有価証券報告書-第11期(令和2年10月1日-令和3年9月30日)

    ID S100MYPB2021-12-06Open
  • EDINET (FSA Japan)

    有価証券報告書-第10期(令和1年10月1日-令和2年9月30日)

    ID S100KAP22020-12-04Open

Extracted from XBRL: 47 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.